Evidence map›Paper›PMID 42149334›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2026

Research Survey on Recognition of Medical Oncology among Medical Students and Junior Residents in Japan.

Yu Ota, Ryoichi Hayashi, Kota Tokunaga, Shiori Endo, Shigemasa Takamizawa, Yosuke Kito, Reiji Nanba, Kei Saito, Masahiro Kanamoto, Rena Takahashi and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yu OtaTokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Koto-Ku, Tokyo, 130-8575, Japan.
Ryoichi HayashiShowa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8555, Japan.
Kota TokunagaFujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake-Cho, Toyoake-Shi, Aichi, 470-1192, Japan.
Shiori EndoNagoya University School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya-Shi, Aichi, 466-8550, Japan.
Shigemasa TakamizawaDepartment of Medical Oncology, Kawasaki Municipal Ida Hospital, 2-27-1 Ida, Nakahara-Ku, Kawasaki-Shi, Kanagawa, 211-0035, Japan.
Yosuke KitoIshikawa Prefectural Central Hospital, 2-1 Kuratsuki-Higashi, Kanazawa-Shi, Ishikawa, 920-8530, Japan.
Reiji NanbaDepartment of Clinical Training Management Center, Kochi Health Sciences Center, 2125-1 Ike, Kochi-Shi, Kochi, 781-8555, Japan.
Kei SaitoJapanese Red Cross Saitama Hospital, 1-5 Shintoshin, Chuo-Ku, Saitama-Shi, Saitama, 330-8553, Japan.
Masahiro KanamotoTokai University School of Medicine, 143 Shimokasuya, Isehara-Shi, Kanagawa, 259-1193, Japan.
Rena TakahashiKeio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582, Japan.
Tsuyoshi ShirakawaClinical Hematology Oncology Treatment Study Group, 1-14-6 Muromigaoka, Nishi-Ku, Fukuoka-Shi, Fukuoka, 819-0030, Japan. twriver1979@gmail.com.ORCID http://orcid.org/0000-0002-9317-8216
Teruhisa AzumaNara Prefecture General Medical Center, 2-897-5 Shichijo-Nishimachi, Nara-Shi, Nara, 630-8581, Japan.
Toshimi TakanoBreast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-Ku, Tokyo, 135-8550, Japan.
Takako Eguchi NakajimaDepartment of Early Clinical Development, Kyoto University Graduate School of Medicine, Yoshida-Konoe-Cho, Sakyo-Ku, Kyoto, 606-8501, Japan.
Hironobu MinamiDepartment of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe-Shi, Hyogo, 650-0017, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeFew reports have investigated the attitudes of medical students and early residents toward medical oncology and their career decisions. This study aimed to assess recognition, interest, and factors influencing the intention to specialize in medical oncology among medical students and junior residents.

methodsA 20-item questionnaire survey was conducted online from November to December 2024. Participants were recruited from medical universities, university hospitals, and general hospitals across Japan. Responses regarding perceptions of medical oncology and decisive factors for career choice were analyzed.

resultsA total of 632 medical students and junior residents completed the survey. Among them, 545 (86%) recognized medical oncology, and 243 (38%) considered it a potential future career. The correlation coefficient between academic year and recognition of medical oncology was 0.976, whereas that between academic year and interest was -0.810. Sensitivity of interest, defined as the proportion of participants considering medical oncology as a career among those interested in it, was highest in third-year students (0.78). Multivariate analysis identified interest in cancer treatment as the strongest predictor of considering medical oncology as a career (contribution rate, 43%; range, 1.62; partial correlation coefficient, 0.28).

conclusionRecognition of medical oncology increased with academic year, whereas interest declined. Interest in cancer treatment was the strongest predictor of intention to specialize in medical oncology.

Indexed as

InterestJunior residentsMedical oncologyMedical studentsRecognition

Identifiers

PMID42149334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.